Last update 23 Jan 2025

CAs x VMAT2

Basic Info

Related Targets
CAsVMAT2

Related

1
Drugs associated with CAs x VMAT2
Quinethazone/Reserpine
Target
CAs x VMAT2
Mechanism
CAs inhibitors [+1]
Active Org.-
Originator Org.
Lederle LaboratoriesLederle Laboratories
Active Indication-
Inactive Indication-
Drug Highest PhaseWithdrawn
First Approval Ctry. / Loc.
US
First Approval Date01 Jan 1982
100 Clinical Results associated with CAs x VMAT2
Login to view more data
100 Translational Medicine associated with CAs x VMAT2
Login to view more data
0 Patents (Medical) associated with CAs x VMAT2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free